Prof Philip Bardin
Monash Lung & Sleep department/Respiratory Research
Monash Medical Centre
Research ActivitiesVirus-associated airway inflammation with emphasis on rhinovirus and RSV in asthma and COPD. Clinical and lab projects are ongoing. Also, established clinical trials section investigating new treatments. Phil Bardin is Professor of Respiratory Medicine in the Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Australia. Since 2008 he has been Director, Lung & Sleep Medicine, Monash University and Medical Centre, Melbourne. He is recognised for investigation of obstructive lung diseases (particularly virus-asthma-COPD exacerbations) and has conducted extensive research of new asthma and COPD therapies. Recently research has also focussed on vocal cord dysfunction in obstructive lung diseases. He is a recipient of ongoing Australian NH&MRC funding, has chaired the Australian NH&MRC Grant Review Panel (Respiratory & Sleep Medicine) and served on the Australian NH&MRC Academy. His professional activities reflect a career-long commitment to research and medical education, particularly in the areas of asthma and COPD. Currently he is Deputy Editor and Editor-in-chief elect of Respirology, official journal of the TSANZ and APSR.
Techniques/ExpertiseCell biology/culture, molecular biology, molecular virology.
Primary culture epithelial and fibroblast cells, access to 'fresh' lung tissue.
CollaborationsProf Bryan Williams
Prof David Jans
Prof Brendan Jenkins
Prof Paul Hertzog
Disease ModelsMouse models infection. Mouse models COPD. In vitro primary cells.
Other Lab MembersSenior post-docs: